This Hershey Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday
This Hershey Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday
這位好時分析師變得看淡；以下是週二的前5家降級評級
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
華爾街頂級分析師改變了對這些頂級公司的展望。如需查看包括升級和降級在內的所有分析師評級變化的完整視圖，請參閱我們的分析師評級頁面。
- B. Riley Securities analyst Eric Wold downgraded the rating for Cinemark Holdings, Inc. (NYSE:CNK) from Buy to Neutral and maintained the price target of $31. Cinemark shares gained 1.3% to close at $28.17 on Monday. See how other analysts view this stock.
- Citigroup analyst Thomas Palmer downgraded The Hershey Company (NYSE:HSY) from Neutral to Sell and slashed the price target from $195 to $182. Hershey shares rose 0.04% to close at $196.41 on Monday. See how other analysts view this stock.
- Alembic Global analyst Peter Skibitski downgraded the rating for Northrop Grumman Corporation (NYSE:NOC) from Overweight to Neutral and announced a price target of $560. Northrop Grumman shares gained 0.5% to close at $512.00 on Monday. See how other analysts view this stock.
- Citigroup analyst Alicia Yap downgraded PDD Holdings Inc. (NASDAQ:PDD) from Buy to Neutral and cut the price target from $194 to $120. PDD shares dipped 28.5% to settle at $100.00 on Monday. See how other analysts view this stock.
- Maxim Group analyst Jason McCarthy downgraded the rating for Cyclo Therapeutics, Inc. (NASDAQ:CYTH) from Buy to Hold. Cyclo Therapeutics shares rose 6.1% to close at $0.8277 on Monday. See how other analysts view this stock.
- b. Riley Securities分析師Eric Wold將Cinemark Holdings, Inc. (紐交所:CNK) 的評級由買入下調至中立，維持目標價爲31美元。週一，Cinemark股票上漲1.3%，收盤價爲28.17美元。想知道其他分析師對這支股票的看法，請參考。
- 花旗集團分析師Thomas Palmer將The Hershey Company (紐交所:HSY) 的評級由中立下調至賣出，將目標價從195美元下調至182美元。週一，好時公司股票上漲0.04%，收盤價爲196.41美元。想知道其他分析師對這支股票的看法，請參考。
- Alembic Global分析師Peter Skibitski將Northrop Grumman Corporation (紐交所:NOC) 的評級由增持下調至中立，並公佈了560美元的目標價。週一，諾斯羅普格魯曼股票上漲0.5%，收盤價爲512.00美元。想知道其他分析師對這支股票的看法，請參考。
- 花旗集團分析師Alicia Yap將PDD Holdings Inc. (納斯達克:PDD) 的評級由買入下調至中立，並將目標價從194美元下調至120美元。週一，PDD股票下跌28.5%，收於100.00美元。想知道其他分析師對這支股票的看法，請參考。
- Maxim Group分析師Jason McCarthy將Cyclo Therapeutics, Inc. (納斯達克:CYTH) 的評級由買入下調至持有。週一，Cyclo Therapeutics股票上漲6.1%，收盤價爲0.8277美元。想知道其他分析師對這支股票的看法，請參考。
Considering buying HSY stock? Here's what analysts think:
考慮購買HSY股票？以下是分析師的看法：
